Stock Fundamentals

Company Information

Company Name
Aadi Bioscience Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US00032Q1040
CIK: 0001422142
CUSIP: 00032Q104
Currency: USD
Full Time Employees: 53
Phone: 424 744 8055
Fiscal Year End: December
IPO Date: Aug 08, 2017
Description:

Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.

Address:

17383 Sunset Boulevard, Pacific Palisades, CA, United States, 90272

Directors & Officers

Name Title Year Born
Dr. David J. Lennon Ph.D. President, CEO & Director 1971
Dr. Neil P. Desai Ph.D. Founder & Director 1965
Mr. Scott M. Giacobello CPA CFO, Treasurer, Investor Relations & Corporate Communications 1970
Mr. Bryan Ball Chief Technical Operations Officer 1971
Dr. David Dornan Ph.D. Chief Scientific Officer 1978
Mr. Stephen M. Rodin J.D. Senior VP of Legal & General Counsel 1976

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 03, 2025 David James Lennon N/A Sale 5.69K $2.35 $13.37K
Mar 03, 2025 Scott M Giacobello N/A Sale 2.81K $2.35 $6.59K
Oct 03, 2024 David James Lennon N/A Sale 9.69K $1.94 $18.80K
Sep 03, 2024 Neil Desai N/A Sale 40.00K $1.71 $68.40K
Aug 05, 2024 Neil Desai N/A Sale 5.65K $1.34 $7.57K
Aug 01, 2024 Neil Desai N/A Sale 15.42K $1.50 $23.12K
Jul 01, 2024 Neil Desai N/A Sale 31.35K $1.45 $45.45K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Suvretta Capital Management, LLC 3.70M Mar 31, 2025 7.91% $0.24 0.00%
venBio Select Advisor LLC 2.85M Mar 31, 2025 6.09% $0.08 0.00%
Qvt Financial LP 2.31M Dec 31, 2024 4.95% $0.65 0.00%
BML Capital Management LLC 1.89M Mar 31, 2025 4.04% $2.72 -9.99%
Longwood Capital Partners LLC 1.85M Dec 31, 2024 3.95% $5.87 0.00%
Ally Bridge Group (NY) LLC 817.94K Mar 31, 2025 1.75% $1.31 0.00%
Vanguard Group Inc 765.99K Mar 31, 2025 1.64% $0.00 0.00%
Renaissance Technologies Corp 462.12K Mar 31, 2025 0.99% $0.00 1.34%
EcoR1 Capital, LLC 345.25K Dec 31, 2024 0.74% $0.04 -81.29%
Bridgeway Capital Management, LLC 315.28K Mar 31, 2025 0.67% $0.01 173.21%
Peapod Lane Capital LLC 241.40K Mar 31, 2025 0.52% $0.48 -45.50%
BlackRock Inc 241.25K Mar 31, 2025 0.52% $0.00 -1.08%
Geode Capital Management, LLC 217.29K Dec 31, 2024 0.46% $0.00 4.09%
Millennium Management LLC 174.00K Dec 31, 2024 0.37% $0.00 -1.58%
Dimensional Fund Advisors, Inc. 107.52K Mar 31, 2025 0.23% $0.00 202.06%
Northern Trust Corp 91.15K Dec 31, 2024 0.19% $0.00 33.12%
State Street Corp 68.74K Mar 31, 2025 0.15% $0.00 0.00%
Citadel Advisors Llc 62.04K Dec 31, 2024 0.13% $0.00 733.36%
UBS Group AG 59.17K Dec 31, 2024 0.13% $0.00 16.70%
Susquehanna International Group, LLP 57.51K Dec 31, 2024 0.12% $0.00 -20.06%

Shares Statistics

Shares Outstanding: 46.29M
Shares Float: 8.31M
% Insiders: 609.80%
% Institutions: 5,001.80%
Short % Float: 7.23%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 499.93K 1.07% ▲ 0.00% Mar 31, 2025
2 Vanguard Institutional Extnd Mkt Idx Tr 247.52K 0.53% ▲ 0.00% Mar 31, 2025
3 Bridgeway Ultra-Small Company 115.40K 0.25% ▲ 23.69% Dec 31, 2024
4 Fidelity Extended Market Index 114.61K 0.25% ▲ 1.49% Mar 31, 2025
5 Fidelity Total Market Index 47.72K 0.10% ▲ 38.59% Mar 31, 2025
6 Extended Equity Market Fund K 43.63K 0.09% ▲ 0.31% Mar 31, 2025
7 iShares Micro-Cap ETF 36.49K 0.08% ▲ 0.00% Apr 30, 2025
8 Fidelity Series Total Market Index 28.25K 0.06% ▲ 6.51% Mar 31, 2025
9 Northern Trust Extended Eq Market Idx 24.53K 0.05% ▲ 0.00% Mar 31, 2025
10 NT Ext Equity Mkt Idx Fd - L 24.53K 0.05% ▲ 0.00% Mar 31, 2025

Valuation Metrics

Enterprise Value: $-11.15M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $94.89M
EBITDA: $-63.40M
Book Value: $2.80
Earnings/Share: $-2.36
Profit Margin: -246.06%
Operating Margin: -149.40%
ROA (TTM): -35.27%
ROE (TTM): -65.95%
Revenue (TTM): $25.07M
Revenue/Share (TTM): $0.93
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 21.00%

Stock Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 3.59x 0.01x 0.25x -438.04x 0.00x
2023-12-31 4.72x 0.00x 0.21x -311.40x -0.01x
2022-12-31 9.56x 0.00x 0.14x -256.33x -0.01x
2021-12-31 9.90x 0.00x 0.14x -167.24x 0.00x
2020-12-31 0.62x -0.82x 1.66x -3.13x -4.13x
2019-12-31 11.87x 0.01x 0.09x N/A -0.01x
2018-12-31 11.73x 0.00x 0.09x -14.37x 0.00x
2017-12-31 5.82x 0.00x 0.17x -202.19x 0.00x
2016-12-31 0.15x -0.99x 6.20x -2.97x -420.00x
2015-12-31 2.76x 0.04x 0.35x -2.73x -6.95x
2014-12-31 0.03x -0.81x 30.46x -3.88x -5.48x
2013-12-31 0.05x -0.89x 15.15x -4.50x -4.91x
2012-12-31 0.08x -0.89x 12.79x -6.55x -3.60x
2011-12-31 0.09x -0.88x 11.29x -10.87x -2.93x
2010-12-31 0.45x -1.46x 2.39x -21.75x -1.46x
2009-12-31 0.45x -1.34x 2.43x N/A N/A
2008-12-31 N/A 0.00x 0.00x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about AADI.US!